Literature DB >> 20676347

Metabolic super scan in F-FDG PET/CT imaging.

Dae-Weung Kim1, Chang Guhn Kim, Soon-Ah Park, Sang-Ah Jung, Sei-Hoon Yang.   

Abstract

A 50-yr-old man presented with intermittent hemoptysis and was diagnosed small cell lung cancer. (18)F-FDG PET/CT for staging demonstrated extensive hypermetabolic lesions throughout the skeleton and liver. Interestingly, skeletal muscles of limbs, mediastinum, bowel, and especially brain showed very low FDG uptake. Because of some characteristics in common with super scan on skeletal scintigraphy, this case could be considered as 'metabolic super scan'.

Entities:  

Keywords:  Extensive Metastasis; FDG PET/CT; Metabolic Super Scan

Mesh:

Substances:

Year:  2010        PMID: 20676347      PMCID: PMC2908805          DOI: 10.3346/jkms.2010.25.8.1256

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

The "super scan" of bone scintigraphy is defined as a bone image that "looks too good." Its characteristics include intense activity in the bones and diminished renal parenchymal activity (1). Su et al. (2) had reported the case of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) super scan involving skeletons, similar to the super scan of bone scintigraphy. A "hepatic super scan" by FDG PET has been reported in a patient with Hodgkin disease who had unusually elevated hepatic radioactivity, in addition to the multiple areas of focal uptake in the chest, mediastinal, left axillary, and abdominal lymph nodes, and the adrenal glands. A liver biopsy demonstrated diffuse hepatic involvement (3). Here we report a case of 18F-FDG PET/CT super scan showing extensive hypermetabolic lesions throughout the skeletons and liver. Contrary to the intense hypermetabolism of skeletons and liver, the skeletal muscles of limbs, mediastinum, bowel, and especially brain showed very low FDG uptake.

CASE REPORT

A 50-yr-old man presented with intermittent hemoptysis. The patient has a history of alcoholic liver cirrhosis and primary hypertension. Subsequent diagnostic CT imaging of chest and abdomen revealed 3.8 cm sized mass in left lower lung with multiple lymph nodes and hepatic metastasis. Excision biopsy of supraclavicular lymph node was performed and histopathologic diagnosis was small cell lung cancer. The patient's mental status was clear and he underwent 18F-FDG PET/CT (Biograph Sensation 16, Siemens Medical Systems, USA) for staging of lung malignancy, 1 hr after injection of 444 MBq (12 mCi) 18F-FDG. 18F-FDG PET/CT demonstrated focal hypermetabolic lung mass in left lower lobe with diffuse and intense hypermetabolism throughout the skeleton and liver. Interestingly, skeletal muscles of limbs, mediastinum, bowel, and especially brain showed very low FDG uptake (Fig. 1). This patient had no medications could disturb cerebral glucose metabolisms, such as corticosteroids and sedatives.
Fig. 1

18F-FDG PET/CT demonstrated focal hypermetabolic lung mass in left lower lobe with diffuse and intense hypermetabolism throughout the skeleton and liver. Interestingly, skeletal muscles of limbs, mediastinum, bowel, and especially brain showed very low FDG uptake. (A) Maximal intensity projection image. (B) Coronal images of torso. (C) Transaxial image of brain. (D) Coronal image of brain.

DISCUSSION

A super scan is well-known phenomenon which is characterized by a strikingly high bone to soft tissue ratio on skeletal scintigraphy, with a uniform symmetrical increase in bone uptake and absent renal visualization (4). The super scan is associated with various malignancies, and most commonly in carcinomas of the prostate, stomach and breast (5). Metastasis from lung cancer rarely causes a super scan, although multiple bone metastases or bone marrow involvement frequently occur in patients with lung cancer (6). Sy et al. (7) hypothesized that the increased uptake of radiopharmaceutical by diseased bone results in reduced phosphate excretion, thereby producing faint renal images in the bone scintigraphy. This case had some characteristics in common with super scan on skeletal scintigraphy. First, even though this is not uncommon feature in patients with extensive metastasis, intense and diffuse hypermetabolism throughout the skeleton and liver was demonstrated. The similar findings had reported in other cases of FDG PET super scan, however, this case had shown the best contrast between metastatic organs and non-metastatic organs (2, 3, 8). Second, FDG uptakes in skeletal muscles of limbs, mediastinum, bowel, and especially brain were remarkably low and this is the unique characteristic of the present case. The faint visualization of the brain, renal cortex, and soft tissue might be the result of extraordinarily high uptake of FDG by bony and hepatic metastatic lesions. Low brain uptake of FDG has been reported when using corticosteroids and sedatives, and these conditions should be taken into consideration (9, 10). The present patient had no medications could disturb cerebral glucose metabolisms, such as corticosteroids and sedatives. Because of some characteristics in common with super scan on skeletal scintigraphy, this case could be considered as 'metabolic super scan'.
  10 in total

1.  Significance of absent or faint kidney sign on bone scan.

Authors:  W M Sy; D Patel; H Faunce
Journal:  J Nucl Med       Date:  1975-06       Impact factor: 10.057

2.  Diffuse increased uptake on bone scan: super scan.

Authors:  Mehrzad Cohen Pour; Yehudit Simon-Corat; Tifha Horne
Journal:  Semin Nucl Med       Date:  2004-04       Impact factor: 4.446

3.  F-18 FDG PET superscan.

Authors:  Hung-Yi Su; Ren-Shyan Liu; Su-Quinn Liao; Shih-Jen Wang
Journal:  Clin Nucl Med       Date:  2006-01       Impact factor: 7.794

4.  Super scan using positron emission tomography in lung cancer patients.

Authors:  Masanori Fujii; Katsuyuki Kiura; Nagio Takigawa; Hiromasa Takeda; Mitsune Tanimoto
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

5.  "Sub"-super scan--manifestation of bone marrow metastases?

Authors:  D A Podoloff; E E Kim
Journal:  Clin Nucl Med       Date:  1989-08       Impact factor: 7.794

6.  Super bone scan.

Authors:  S M Manier; D Van Nostrand
Journal:  Semin Nucl Med       Date:  1984-01       Impact factor: 4.446

7.  Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study.

Authors:  W D Gaillard; T Zeffiro; S Fazilat; C DeCarli; W H Theodore
Journal:  Epilepsia       Date:  1996-06       Impact factor: 5.864

8.  Absent or faint renal uptake on bone scan. Etiology and significance in metastatic bone disease.

Authors:  S E Kim; D Y Kim; D S Lee; J K Chung; M C Lee; C S Koh
Journal:  Clin Nucl Med       Date:  1991-08       Impact factor: 7.794

9.  Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: hepatic 'superscan'.

Authors:  Sandip Basu; Narendra Nair
Journal:  Clin Nucl Med       Date:  2004-10       Impact factor: 7.794

10.  Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.

Authors:  M J Fulham; A Brunetti; L Aloj; R Raman; A J Dwyer; G Di Chiro
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

  10 in total
  10 in total

1.  The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.

Authors:  Jean-Mathieu Beauregard; Michael S Hofman; Grace Kong; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  Peritoneal Super Scan on 18F-FDG PET/CT in two patients with Lymphoma.

Authors:  Yassir Benameur; Sanâa Touil; Omar Ait Sahel; Salah Nabih Oueriagli; Abdelhamid Biyi; Abderrahim Doudouh
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

3.  Technetium 99m PSMA Superscan Mimicking a Bone Scan Gone Wrong.

Authors:  Evbuomwan Osayande; Fourie Carika; Engelbrecht Gerrit
Journal:  Nucl Med Mol Imaging       Date:  2022-04-19

Review 4.  Clinical Pearls: Etiologies of Superscan Appearance on Fluorine-18-Fludeoxyglucose Positron Emission Tomography-Computed Tomography.

Authors:  John Joseph Manov; Patrick J Roth; Russ Kuker
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec

5.  Peritoneal Super Scan on 18F - FDG PET-CT in a Patient of Burkitt's Lymphoma.

Authors:  Shambo Guha Roy; Girish Kumar Parida; Sarthak Tripathy; Abhinav Singhal; Shamim Ahmed Shamim; Madhavi Tripathi
Journal:  Indian J Nucl Med       Date:  2017 Apr-Jun

6.  Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report.

Authors:  Ismaheel Lawal; Alfred Ankrah; Kehinde Ololade; Moshe Modiselle; Mike Sathekge
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  F-18 fluorodeoxyglucose positron emission tomography "super scan" in a patient of metastatic primitive neuroectodermal tumor of the kidney.

Authors:  Gaurav Malhotra; Archana Swami; Pinky Shah; Neha Mittal; Sunny J Gandhi; Bp Tiwari; Praful V Jatale; Ramesh V Asopa
Journal:  Indian J Nucl Med       Date:  2012-04

8.  Superscan caused by renal osteodystrophy: Observed on 18F FDG PET/CT scan.

Authors:  Nasrin Ghesani; Jin Jung; Shyam Patel; Tekchand Ramchand
Journal:  Indian J Nucl Med       Date:  2013-10

9.  Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan.

Authors:  Krishan Kant Agarwal; Madhavi Tripathi; Rajeev Kumar; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun

10.  Superscan Appearance of 68Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer.

Authors:  Zehra Pınar Koç; Pınar Pelin Özcan; Vehbi Erçolak; Mehmet Reyhan
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.